Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Wang, Qihui, Zhang, Yanfang, Wu, Lili, Niu, Sheng, Song, Chunli, Zhang, Zengyuan, Lu, Guangwen, Qiao, Chengpeng +6 more·2020·Cell
Cited by (1,009)
Items 601–700 of 1,009
- Versatile role of ACE2-based biosensors for detection of SARS-CoV-2 variants and neutralizing antibodiesJong-Hwan Lee, Yungmin Lee, Sung Kyun Lee, Jung Kim, Chang‐Seop Lee, Nam Hoon Kim, Hong Gi Kim · 2022 · Biosensors and Bioelectronics
- AGTR2, One Possible Novel Key Gene for the Entry of SARS-CoV-2 Into Human CellsChunmei Cui, Chuanbo Huang, Wanlu Zhou, Xiangwen Ji, Fenghong Zhang, Liang Wang, Yuan Zhou, Qinghua Cui · 2020 · IEEE Transactions on Computational Biology and Bioinformatics
- Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discoveryPaulchamy Chellapandi, Sivashanmuga Vadivel Saranya · 2020 · Medicinal Chemistry Research
- Comprehensive annotations of the mutational spectra of SARS‐CoV‐2 spike protein: a fast and accurate pipelineM. Shaminur Rahman, M. Rafiul Islam, M. Nazmul Hoque, A. S. M. Rubayet Ul Alam, Masuda Akther, Joynob Akter Puspo, Salma Akter, Azraf Anwar, Munawar Sultana, M. Anwar Hossain · 2020 · Transboundary and Emerging Diseases
- Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapiesGirish Pathangey, Priyal Fadadu, Alexa R. Hospodar, Amr E. Abbas · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
- Intermolecular π–π Stacking Interactions Made VisibleBrian J. J. Timmer, Tiddo J. Mooibroek · 2020 · Journal of Chemical Education
- Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variantsTingting Li, Xiaojian Han, Chenjian Gu, Hangtian Guo, Huajun Zhang, Yingming Wang, Chao Hu, Kai Wang, Fengjiang Liu, Feiyang Luo et al. · 2021 · Nature Communications
- The Genetic Variant of SARS-CoV-2: Would it matter for Controlling the Devastating Pandemic?Shuxin Guo, Kefang Liu, Jun Zheng · 2021 · International Journal of Biological Sciences
- SARS-CoV-2 Omicron Variant Binds to Human Cells More Strongly than the Wild Type: Evidence from Molecular Dynamics SimulationHoang Linh Nguyen, Nguyen Quoc Thai, Phuong Hoang Nguyen, Mai Suan Li · 2022 · The Journal of Physical Chemistry B
- Molecular insights into the adaptive evolution of SARS-CoV-2 spike proteinZhuocheng Yao, Lin Zhang, Yuange Duan, Xiaolu Tang, Jian Lü · 2024 · Journal of Infection
- The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategiesVaishali Waman, Neeladri Sen, Mihály Váradi, Antoine Daina, Shoshana J. Wodak, Vincent Zoete, Sameer S Velankar, Christine Anne Orengo · 2020 · Briefings in Bioinformatics
- The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological ResponsesEleazar Ramírez Hernández, Luis Fernando Hernández-Zimbrón, Nayeli Martínez-Zúñiga, Juan José Leal-García, Violeta Ignacio Hernández, Luis Eduardo Ucharima-Corona, Eduardo Pérez‐Campos, Edgar Zenteno · 2021 · Viral Immunology
- Production of high‐quality SARS‐CoV‐2 antigens: Impact of bioprocess and storage on glycosylation, biophysical attributes, and ELISA serologic tests performanceRute Castro, Lígia S. Nobre, Rute P. Eleutério, Mónica Thomaz, António Pires, Sandra Monteiro, Sónia Mendes, Ricardo A. Gomes, João J. Clemente, Marcos F. Q. Sousa et al. · 2021 · Biotechnology and Bioengineering
- Lactiplantibacillus plantarum as a Potential Adjuvant and Delivery System for the Development of SARS-CoV-2 Oral VaccinesJulio Villena, Chang Li, María Guadalupe Vizoso-Pinto, Jacinto Sacur, Linzhu Ren, Haruki Kitazawa · 2021 · Microorganisms
- In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish FarmsRia Lassaunière, Jannik Fonager, Morten Rasmussen, Anders Frische, Charlotta Polacek, Thomas Bruun Rasmussen, Louise Lohse, Graham J. Belsham, Alexander P. Underwood, Anni Assing Winckelmann et al. · 2021 · Frontiers in Microbiology
- Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discoveryZhonglei Wang, Liyan Yang, Xian‐En Zhao · 2021 · Computational and Structural Biotechnology Journal
- SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A reviewJahangir Emrani, Maryam Ahmed, Liesl K. Jeffers-Francis, John C. Teleha, Chishimba Nathan Mowa, Robert Howard Newman, Misty D. Thomas · 2021 · International Journal of Biological Macromolecules
- Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused OverviewRukmankesh Mehra, Kasper P. Kepp · 2021 · ACS Infectious Diseases
- Mechanisms contributing to adverse outcomes of COVID-19 in obesityManu Sudhakar, Winfred Sofi Beaula, Gowri Meiyazhagan, Venkatachalam Deepa Parvathi · 2022 · Molecular and Cellular Biochemistry
- SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug DiscoveriesHatem A. Elshabrawy · 2020 · Vaccines
- Gastrointestinal Symptoms Associated With Unfavorable Prognosis of COVID-19 Patients: A Retrospective StudyRong Chen, Yanli Yu, Wei Li, Ya Liu, Jingxiao Lu, Fangyue Chen, Qin Zhou, Zhongyuan Xia, Ling Gao, Qingtao Meng et al. · 2020 · Frontiers in Medicine
- Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2Léna Petit, Léa Vernès, Jean‐Paul Cadoret · 2021 · Journal of Applied Phycology
- Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domainZachariah P. Schuurs, Edward Hammond, Stefano Elli, Timothy Robert Rudd, Courtney J. Mycroft‐West, Marcelo Andrade de Lima, Mark Andrew Skidmore, Richard Torbjörn Gustav Karlsson, Yen‐Hsi Chen, Ieva Bagdonaite et al. · 2021 · Computational and Structural Biotechnology Journal
- The Development of SARS-CoV-2 Variants: The Gene Makes the DiseaseRaquel Pérez-Gómez · 2021 · Journal of Developmental Biology
- A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2Thomas S. Fulford, Huy Trần Văn, Nicholas A. Gherardin, Shuning Zheng, Marcin Ciula, Heidi E. Drummer, Samuel J. Redmond, Hyon‐Xhi Tan, Irene Boo, Fan Li et al. · 2021 · EBioMedicine
- Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2Tomokazu Ohishi, Takayuki Hishiki, Mirza S. Baig, Sajjan Rajpoot, Uzma Saqib, Tomohiko Takasaki, Yukihiko Hara · 2022 · PLoS ONE
- Potential of Nano-Antioxidants and Nanomedicine for Recovery from Neurological Disorders Linked to Long COVID SyndromeThelma Akanchise, Angelina Angelova · 2023 · Antioxidants
- Recent developments in molecular modeling tools and applications related to pharmaceutical and biomedical researchPaola Peluso, Bezhan Chankvetadze · 2023 · Journal of Pharmaceutical and Biomedical Analysis
- Human transferrin receptor can mediate SARS-CoV-2 infectionZhiyi Liao, Chaoming Wang, Xiaopeng Tang, Mengli Yang, Zilei Duan, Lei Liu, Shuaiyao Lu, Lei Ma, Ruomei Cheng, Wang Gan et al. · 2024 · Proceedings of the National Academy of Sciences
- COVID-19 : physiopathologie d’une maladie à plusieurs visagesVincent Bonny, Alexis Maillard, Cyril Mousseaux, Léo Plaçais, Quentin Richier · 2020 · La Revue de Médecine Interne
- Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to BedsideJie Yu, Peiwei Chai, Shengfang Ge, Xianqun Fan · 2020 · Frontiers in Cell and Developmental Biology
- Flexible, Functional, and Familiar: Characteristics of SARS-CoV-2 Spike Protein EvolutionDianita S. Saputri, Songling Li, Floris J. van Eerden, John Rozewicki, Zichang Xu, Hendra Saputra Ismanto, Ana Davila, Shunsuke Teraguchi, Kazutaka Katoh, Daron M. Standley · 2020 · Frontiers in Microbiology
- High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoproteinIbrahim E. Awad, Abd Al‐Aziz A. Abu‐Saleh, Sweta Sharma, Arpita Yadav, Raymond A. Poirier · 2020 · Journal of Biomolecular Structure and Dynamics
- ACE2: from protection of liver disease to propagation of COVID-19Fiona J. Warner, Harinda Rajapaksha, Nicholas Adam Shackel, Chandana B. Herath · 2020 · Clinical Science
- A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2Hebang Yao, Hongmin Cai, Tingting Li, Bingjie Zhou, Wenming Qin, Dimitri Lavillette, Dianfan Li · 2021 · PLoS Pathogens
- Computational Mutagenesis at the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Binding Interface: Comparison with Experimental EvidenceErik Laurini, Domenico Marson, Suzana Aulić, Alice Fermeglia, Sabrina Pricl · 2021 · ACS Nano
- Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLsAnita Gupta, Gopal S. Gupta · 2021 · Molecular and Cellular Biochemistry
- Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analoguesLeentje Persoons, Evelien Vanderlinden, Laura Vangeel, Xinyu Wang, Thuc Nguyen Dan, Caroline Shi-Yan Foo, Pieter Leyssen, Johan H. Neyts, Dirk Jochmans, Dominique Schols et al. · 2021 · Antiviral Research
- Inhibition of ACE2‐Spike Interaction by an ACE2 Binder Suppresses SARS‐CoV‐2 EntryYoung‐Hee Shin, Kiyoung Jeong, Jihye Lee, Hyo‐Jung Lee, Junhyeong Yim, Jonghoon Kim, Seungtaek Kim, Seung Bum Park · 2022 · Angewandte Chemie International Edition
- A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 InfectionLuise Hassler, Jan A Wysocki, Ian Arthur Gelarden, Isha Sharma, Αναστασία Τοματσίδου, Minghao Ye, Haley Gula, Vlad Nicoleascu, Glenn C. Randall, Sergii Pshenychnyi et al. · 2022 · Journal of the American Society of Nephrology
- Activation of ang-(1-7)/mas receptor is a possible strategy to treat coronavirus (SARS-CoV-2) infectionMagalhaes, Giselle Santos, Rodrigues-Machado, Maria da Gloria, Motta-Santos, Daisy, Campagnole-Santos, Maria Jose, Santos, Robson A. Souza · 2020 · Frontiers in Physiology
- Ligand‐centered assessment of SARS‐CoV‐2 drug target models in the Protein Data BankAlexander Wlodawer, Zbigniew Dauter, Ivan G. Shabalin, Miroslaw J. Gilski, Dariusz Brzeziński, Marcin Kowiel, Wladek Minor, Bernhard Rupp, Mariusz Jaskólski · 2020 · FEBS Journal
- Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spikeAntoni G. Wrobel · 2023 · Current Opinion in Structural Biology
- Engineering Cellular Vesicles for ImmunotherapyXinyu Lin, Ludan Yue, Ke Cheng, Lang Rao · 2025 · Accounts of Materials Research
- SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney FailureAlessandra Stasi, Giuseppe Castellano, Elena Ranieri, Barbara Infante, Giovanni Stallone, Loreto Gesualdo, Giuseppe Stefano Netti · 2020 · Journal of Clinical Medicine
- Axial Chiral Binaphthoquinone and Perylenequinones from the Stromata of Hypocrella bambusae Are SARS-CoV-2 Entry InhibitorsYuting Li, Chan Yang, Yan Ling Wu, Jun‐Jiang Lv, Xiao Feng, Xiaofei Tian, Zhengzheng Zhou, Xiaoyan Pan, Shuwen Liu, Liwen Tian · 2021 · Journal of Natural Products
- The SARS‐unique domain (SUD) of SARS‐CoV and SARS‐CoV‐2 interacts with human Paip1 to enhance viral RNA translationJian Lei, Yue Ma-Lauer, Yinze Han, M. Thoms, R. Buschauer, J. Jores, V. Thiel, R. Beckmann, Wen Deng, H. Leonhardt et al. · 2021 · EMBO Journal
- COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the HeartMaurizio Pesce, Piergiuseppe Agostoni, Hans Erik Bøtker, Bianca J.J.M. Brundel, Sean M. Davidson, Raffaele De Caterina, Péter Ferdinandy, Henrique Girão, Mariann Gyöngyösi, Jean‐Sébastien Hulot et al. · 2021 · Cardiovascular Research
- Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 VariantsLinda van Oosten, Jort J. Altenburg, Cyrielle E. Fougeroux, Corinne Geertsema, Fred van den End, Wendy A. C. Evers, Adrie H. Westphal, Simon Lindhoud, W. van den Berg, Daan C. Swarts et al. · 2021 · mBio
- Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein‐enhanced fitness in SARS‐COV ‐2Olaposi Idowu Omotuyi, Oyekanmi Nash, O. Basiru Ajiboye, C. Gift Iwegbulam, E. Babatunji Oyinloye, O. Abimbola Oyedeji, Z. Abimbola Kashim, Kunle Okaiyeto · 2020 · Journal of Computational Chemistry
- Multiple functions of stress granules in viral infection at a glanceYuelin Guan, Yan Wang, Xudong Fu, Guannan Bai, Xue Li, Jian‐Hua Mao, Yong‐Bin Yan, Lidan Hu · 2023 · Frontiers in Microbiology
- Human coronavirus spike protein-host receptor recognitionLalitha Guruprasad · 2020 · Progress in Biophysics and Molecular Biology
- Review of COVID‐19 and male genital tractFarzam Sheikhzadeh Hesari, Seyedeh Shaghayegh Hosseinzadeh, Mohammad Ali Asl Monadi Sardroud · 2020 · Andrologia
- Conformational flexibility and structural variability of SARS-CoV2 S proteinIshika Pramanick, Nayanika Sengupta, Suman Mishra, Suman Pandey, Nidhi Girish, Alakta Das, Somnath Dutta · 2021 · Structure
- Variable posttranslational modifications of severe acute respiratory syndrome coronavirus 2 nucleocapsid proteinNitin T. Supekar, Asif Shajahan, Anne S. Gleinich, Daniel S. Rouhani, Christian Heiß, Digantkumar Gopaldas Chapla, Kelley W. Moremen, Parastoo Azadi · 2021 · Glycobiology
- ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactionsDaniel J. Rawle, Thuy T. Le, Troy D. Dumenil, Kexin Yan, Bing Tang, Wilson Nguyen, Daniel Watterson, Naphak Modhiran, Jody Hobson‐Peters, Cameron Bishop et al. · 2021 · PLoS Pathogens
- Role of genetic variants and host polymorphisms on COVID‐19: From viral entrance mechanisms to immunological reactionsAbolfazl Adli, Mandana Rahimi, Reza Khodaie, Niloofar Hashemzaei, Sayed Mostafa Hosseini · 2022 · Journal of Medical Virology
- Cryo-EM Structures Delineate a pH-Dependent Switch that Mediates Endosomal Positioning of SARS-CoV-2 Spike Receptor-Binding DomainsTongqing Zhou, Yaroslav Tsybovsky, Adam S. Olia, Jason Gorman, Micah Rapp, Gabriele Cerutti, Gwo‐Yu Chuang, Phinikoula S. Katsamba, Alexandra F. Nazzari, Jared M. Sampson et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
- Transferrin receptor is another receptor for SARS-CoV-2 entryXiaopeng Tang, Mengli Yang, Zilei Duan, Zhiyi Liao, Lei Liu, Ruomei Cheng, Mingqian Fang, Wang Gan, Hongqi Liu, Jingwen Xu et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
- Viral pathogenesis of SARS-CoV-2 infection and male reproductive healthShubhadeep Roychoudhury, Anandan Das, Kavindra Kumar Kesari, Kavindra Kumar Kesari, Shatabhisha Roychoudhury, Saurabh Kumar Jha, Raghavender Goud Kosgi SR, Arun Paul Choudhury, Norbert Lukáč, Nithar Ranjan Madhu et al. · 2021 · Open Biology
- Understanding the Molecular Biology of SARS-CoV-2 and the COVID-19 Pandemic: A ReviewSarah F. Alsobaie · 2021 · Infection and Drug Resistance
- Interaction of selected terpenoids with two SARS-CoV-2 key therapeutic targets: An in silico study through molecular docking and dynamics simulationsSalvatore Vincenzo Giofrè, Edoardo Napoli, Nunzio Iraci, Antonio Speciale, Francesco Cimino, Claudia Muscarà, Maria Sofia Molonia, Giuseppe Ruberto, Antonella Saija · 2021 · Computers in Biology and Medicine
- Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approachReem Yussuf AlJindan, Abeer M. Al‐Subaie, Ahoud I. Al-Ohali, D. Thirumal Kumar, C. George Priya Doss, Balu Kamaraj · 2021 · Computers in Biology and Medicine
- Generation of a Sleeping Beauty Transposon-Based Cellular System for Rapid and Sensitive Screening for Compounds and Cellular Factors Limiting SARS-CoV-2 ReplicationMarek Widera, Alexander Wilhelm, Tuna Toptan, Johanna M. Raffel, Eric Kowarz, Fabian Roesmann, Finn Grözinger, Anna Lena Siemund, Vanessa Luciano, Marius Külp et al. · 2021 · Frontiers in Microbiology
- Trypsin enhances SARS-CoV-2 infection by facilitating viral entryYeeun Kim, Guehwan Jang, Duri Lee, Nara Kim, Jeong Won Seon, Young-Hoan Kim, Changhee Lee · 2022 · Archives of Virology
- Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programsLipin Loo, Matthew A. Waller, Cesar L. Moreno, Alexander J. Cole, Alberto Ospina Stella, Oltin-Tiberiu Pop, Ann-Kristin Jochum, Omar Hasan Ali, Christopher E. Denes, Zina Hamoudi et al. · 2023 · PLoS Biology
- Nucleic acid-based therapy for coronavirus disease 2019Ravikant Piyush, Keshav Rajarshi, Aroni Chatterjee, Rajni Khan, Shashikant Ray · 2020 · Heliyon
- SARS-CoV-2 mutation 614G creates an elastase cleavage site enhancing its spread in high AAT-deficient regionsChandrika Bhattacharyya, Chitrarpita Das, Arnab Ghosh, Animesh Kumar Singh, Souvik Mukherjee, Partha Pratim Majumder, Analabha Basu, Nidhan K. Biswas · 2021 · Infection Genetics and Evolution
- Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteinsKim M. Bouwman, Ilhan Tomris, Hannah L. Turner, Roosmarijn van der Woude, Tatiana M. Shamorkina, Gerlof P. Bosman, Barry Rockx, Sander Herfst, Joost Snijder, Bart L. Haagmans et al. · 2021 · PLoS Pathogens
- Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression SystemsIuliia A. Merkuleva, D. Shcherbakov, M. B. Borgoyakova, D. Shanshin, A. P. Rudometov, L. Karpenko, S. Belenkaya, A. A. Isaeva, V. S. Nesmeyanova, E. Kazachinskaia et al. · 2022 · Vaccines
- SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entryBo Yang, Yuanyuan Jia, Yumin Meng, Ying Xue, Kefang Liu, Yan Li, Shichao Liu, Xiaoxiong Li, Kaige Cui, Lina Shang et al. · 2022 · Proceedings of the National Academy of Sciences
- Molecular Virology of SARS-CoV-2 and Related CoronavirusesYu-An Kung, Kuo-Ming Lee, Huan-Jung Chiang, Sheng‐Yu Huang, Chung-Jung Wu, Shin‐Ru Shih · 2022 · Microbiology and Molecular Biology Reviews
- Susceptibilities of Human ACE2 Genetic Variants in Coronavirus InfectionWenlin Ren, Yunkai Zhu, Jun Lan, Hedi Chen, Yuyan Wang, Hongyang Shi, Fei Feng, D. W. Chen, Brianna J. Close, Xiaomin Zhao et al. · 2021 · Journal of Virology
- Trends of mutation accumulation across global SARS-CoV-2 genomes: Implications for the evolution of the novel coronavirusChayan Roy, Santi M. Mandal, Suresh Kumar Mondal, Shriparna Mukherjee, Tarunendu Mapder, Wriddhiman Ghosh, Ranadhir Chakraborty · 2020 · Genomics
- Kinetics and isotype assessment of antibodies targeting the spike protein receptor‐binding domain of severe acute respiratory syndrome‐coronavirus‐2 in COVID‐19 patients as a function of age, biological sex and disease severityNancy R. Graham, Annalis Whitaker, Camilla A. Strother, Ashley K. Miles, Dore Grier, Benjamin D. McElvany, Emily A. Bruce, Matthew E. Poynter, Kristen K. Pierce, Beth D. Kirkpatrick et al. · 2020 · Clinical & Translational Immunology
- A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2Rajarshi Bhattacharya, Aayatti Mallick Gupta, Suranjita Mitra, Sukhendu Mandal, Swadesh Ranjan Biswas · 2020 · Virology
- Development of a Fast SARS-CoV-2 IgG ELISA, Based on Receptor-Binding Domain, and Its Comparative Evaluation Using Temporally Segregated Samples From RT-PCR Positive IndividualsFarha Mehdi, Souvick Chattopadhyay, Ramachandran Thiruvengadam, Yadav Sarla, Manjit Kumar, Sangita Kumari Sinha, Sandeep Goswami, Pallavi Kshetrapal, Nitya Wadhwa, Uma Chandra Mouli Natchu et al. · 2021 · Frontiers in Microbiology
- Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection EfficiencyAhmed L. Alaofi, Mudassar Shahid · 2021 · Biomolecules
- Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal studyHouda Amellal, Najlaa Assaid, Hicham Charoute, Khadija Akarid, Abderrahmane Maaroufi, Sayeh Ezzikouri, M’hammed Sarih · 2023 · PLoS ONE
- Markov State Models and Perturbation-Based Approaches Reveal Distinct Dynamic Signatures and Hidden Allosteric Pockets in the Emerging SARS-Cov-2 Spike Omicron Variant Complexes with the Host Receptor: The Interplay of Dynamics and Convergent Evolution Modulates Allostery and Functional MechanismsSian Xiao, Mohammed Alshahrani, Grace Gupta, Peng Tao, Gennady M. Verkhivker · 2023 · Journal of Chemical Information and Modeling
- Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteinsWeiwei Li, Zepeng Xu, Tianhui Niu, Yufeng Xie, Zhennan Zhao, Dedong Li, Qingwen He, Wenqiao Sun, Kaiyuan Shi, Wenjing Guo et al. · 2024 · The EMBO Journal
- ACE2, the Receptor that Enables Infection by SARS‐CoV‐2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 ModulatorsLissy Z. F. Gross, Mariana Sacerdoti, Albrecht Piiper, Stefan Zeuzem, Alejandro E. Leroux, Ricardo M. Biondi · 2020 · ChemMedChem
- Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV SpikeJoão M. Trigueiro-Louro, Vanessa Correia, Inês Figueiredo-Nunes, Marta Gíria, Helena Rebelo‐de‐Andrade · 2020 · Computational and Structural Biotechnology Journal
- Binding of SARS‐CoV‐2 to Cell Receptors: A Tale of Molecular EvolutionSantiago A. Gómez, Natalia Rojas‐Valencia, Sara Gómez, Franco Egidi, Chiara Cappelli, Albeiro A. Restrepo · 2020 · ChemBioChem
- Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patientsQ. Yan, P. He, Xiaohan Huang, K. Luo, Yu-Di Zhang, Haisu Yi, Qian Wang, Feng Li, Rui-Tian Hou, Xiaodi Fan et al. · 2021 · Emerging Microbes and Infections
- Carbon Nanotube Mask Filters and Their Hydrophobic Barrier and Hyperthermic Antiviral Effects on SARS-CoV-2Sangsu Lee, Jeong‐Seok Nam, Jiye Han, Qiang Zhang, Esko I. Kauppinen, Il Jeon · 2021 · ACS Applied Nano Materials
- Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severityCharitha Gangadharan, Rupa Ahluwalia, Alben Sigamani · 2021 · World Journal of Diabetes
- Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variantsWan-Ling Wu, Chen-Yi Chiang, Szu-Chia Lai, Chia-Yi Yu, Yu‐Ling Huang, Hung‐Chun Liao, Ching‐Len Liao, Hsin–Wei Chen, Shih‐Jen Liu · 2022 · JCI Insight
- Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptorTümay Capraz, Nikolaus F. Kienzl, Elisabeth Laurent, Jan Walther Perthold, Esther Föderl-Höbenreich, Clemens Grünwald‐Gruber, Daniel Maresch, Vanessa Monteil, Janine Niederhöfer, Gerald Wirnsberger et al. · 2021 · eLife
- Single-Cell Immunobiology of the Maternal–Fetal InterfaceDerek Miller, Valeria Garcia‐Flores, Roberto J. Romero, José Galaz, Roger Piqué-Regi, Nardhy Gomez‐Lopez · 2022 · The Journal of Immunology
- Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 InfectionTitus Abiola Olukitibi, Zhujun Ao, Bryce M. Warner, Rodrigo Unat, Darwyn Kobasa, Xiaojian Yao · 2023 · Vaccines
- The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infectionAmirhosein Faghihkhorasani, Hanan Hassan Ahmed, Noor Muhammad Mashool, Mariem Alwan, Marjan Assefi, Aya Hussein Adab, Saman Yasamineh, Omid Gholizadeh, Moein Baghani · 2023 · Virology Journal
- Classification of five SARS-CoV-2 serotypes based on RBD antigenicitiesShixiong Hu, Chunli Wu, Xinkai Wu, Xuehui Ma, Chang Shu, Qian Chen, Anqi Zheng, Huiting Yang, Jian Lü, Pei Du et al. · 2023 · 中国科学通报:英文版
- Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus‑2 and the Receptor of Human Angiotensin-Converting Enzyme 2. Effects of Possible LigandsCristina García‐Iriepa, Cécilia Hognon, Antonio Francés‐Monerris, Isabel Iriepa, Tom Miclot, Giampaolo Barone, Antonio Monari, Marco Marazzi · 2020 · The Journal of Physical Chemistry Letters
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer PatientsSara Ravaioli, Michela Tebaldi, Eugenio Fonzi, Davide Angeli, Massimiliano Mazza, Fabio Nicolini, Alessandro Lucchesi, Francesca Fanini, Francesca Pirini, Maria Maddalena Tumedei et al. · 2020 · Cell Transplantation
- Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?Ligong Lu, Hui Zhang, Meixiao Zhan, Jun Jiang, Hua Yin, Danielle J. Dauphars, Shi-You Li, Yong Li, You-Wen He · 2020 · Science China Life Sciences
- Animal Coronaviruses and SARS-COV-2 in Animals, What Do We Actually Know?Paolo Bonilauri, Gianluca Rugna · 2021 · Life
- D936Y and Other Mutations in the Fusion Core of the SARS-CoV-2 Spike Protein Heptad Repeat 1: Frequency, Geographical Distribution, and Structural EffectRomina Oliva, Abdul Rajjak Shaikh, Andrea Petta, Anna Vangone, Luigi Cavallo · 2021 · Molecules
- Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain DerivativeSameer Kumar Malladi, Unnatiben Rajeshbhai Patel, Raju S Rajmani, Randhir Singh, Suman Pandey, Sahil Kumar, Sara Khaleeq, Petrus Jansen van Vuren, Shane Riddell, Sarah Goldie et al. · 2021 · ACS Infectious Diseases
- Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammationWei Wang, Shasha Li, Xinfeng Xu, Chan Yang, Xiaoge Niu, Shuxian Yin, Xiaoyan Pan, Wei Xü, Guodong Hu, Chan Wang et al. · 2021 · Acta Pharmacologica Sinica